GE Healthcare has teamed up with Boston Scientific to offer an end-to-end interventional cardiac care portfolio in Southeast Asia.

As part of the collaboration, the companies will offer a full spectrum of new solutions, which will range from diagnostic to percutaneous coronary intervention (PCI).

These solutions will help healthcare providers to treat their patients and offer better heart care.

GE Healthcare Association of Southeast Asian Nations (ASEAN) president and CEO Chris Khang said: “Bridging the industry gap in providing an end-to-end cardiac care centre for healthcare providers, this partnership will see the integration of cardiac care solutions, from cath labs to intravascular ultrasound (IVUS), serving as a comprehensive portfolio for heart surgeons.

“These solutions will be crucial in unlocking the potential of interventional cardiology and is a step forward in delivering precision health to the region.”

The collaboration between the two companies, which have strong interventional cardiology portfolios, is claimed to be the first-of-its-kind in Southeast Asia.

Under the partnership, the advanced medical devices and capabilities of Boston Scientific will be combined with medical imaging systems, such as cardiac catheterisation lab and related software, from GE Healthcare, proving support from diagnosis to treatment as well as for monitoring the cardiac patient-care pathway.

Boston Scientific Korea and ASEAN vice-president and managing director Min Hang Heo said: “By integrating access to the latest medical innovations and cutting-edge technology for our joint customers and the patients they care for, we can ensure treatment of patients of all degrees of complexity is readily available.”

Last month, GE Healthcare concluded the acquisition of BK Medical from Altaris Capital Partners for $1.45bn in cash.